These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line. Hua J; Mutch DG; Herzog TJ Gynecol Oncol; 2005 Jul; 98(1):31-8. PubMed ID: 15921732 [TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effect of pheophorbide a-mediated photodynamic therapy and its synergistic effect with doxorubicin on multiple drug-resistant uterine sarcoma cell MES-SA/Dx5. Cheung KK; Chan JY; Fung KP Drug Chem Toxicol; 2013 Oct; 36(4):474-83. PubMed ID: 23560455 [TBL] [Abstract][Full Text] [Related]
5. FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells. Hung TH; Chen CM; Tseng CP; Shen CJ; Wang HL; Choo KB; Chong KY Int J Biochem Cell Biol; 2014 Aug; 53():55-65. PubMed ID: 24814288 [TBL] [Abstract][Full Text] [Related]
6. Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin. Chang CC; Huang LH; Chiang W; Hsia SM Phytomedicine; 2018 Aug; 47():69-80. PubMed ID: 30166110 [TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors. Friel AM; Zhang L; Pru CA; Clark NC; McCallum ML; Blok LJ; Shioda T; Peluso JJ; Rueda BR; Pru JK Cancer Lett; 2015 Jan; 356(2 Pt B):434-42. PubMed ID: 25304370 [TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of proteins responsible for the development of doxorubicin resistance in human uterine cancer cells. Lin ST; Chou HC; Chang SJ; Chen YW; Lyu PC; Wang WC; Chang MD; Chan HL J Proteomics; 2012 Oct; 75(18):5822-47. PubMed ID: 22889595 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of P-glycoprotein-mediated transport by S-adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells. Angelini A; Di Pietro R; Centurione L; Castellani ML; Conti P; Porreca E; Cuccurullo F J Biol Regul Homeost Agents; 2012; 26(3):495-504. PubMed ID: 23034269 [TBL] [Abstract][Full Text] [Related]
10. Allopurinol, furosemide and a phytotherapeutic agent (Bazoton uno) reverse P-glycoprotein-mediated doxorubicin resistance in human uterine sarcoma MES-SA/Dx5 cells: a novel therapeutic perspective. Angelini A; Centurione MA; Di Pietro R; Centurione L J Biol Regul Homeost Agents; 2019 May-Jun,; 33(3):991-997. PubMed ID: 31162035 [No Abstract] [Full Text] [Related]
11. Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy. Angelini A; Conti P; Ciofani G; Cuccurullo F; Di Ilio C J Biol Regul Homeost Agents; 2013; 27(4):1029-37. PubMed ID: 24382184 [TBL] [Abstract][Full Text] [Related]
12. Human sarcoma cell lines MES-SA and MES-SA/Dx5 as a model for multidrug resistance modulators screening. Wesolowska O; Paprocka M; Kozlak J; Motohashi N; Dus D; Michalak K Anticancer Res; 2005; 25(1A):383-9. PubMed ID: 15816562 [TBL] [Abstract][Full Text] [Related]
13. Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines. Roomi MW; Kalinovsky T; Roomi NW; Rath M; Niedzwiecki A Oncol Rep; 2012 Jan; 27(1):17-27. PubMed ID: 21947138 [TBL] [Abstract][Full Text] [Related]
14. Identification of up- and down-regulated proteins in doxorubicin-resistant uterine cancer cells: reticulocalbin-1 plays a key role in the development of doxorubicin-associated resistance. May EW; Lin ST; Lin CC; Chang JF; Hung E; Lo YW; Lin LH; Hu RY; Feng CL; Lin DY; Wu SB; Lee WC; Lyu KW; Chou HC; Chan HL Pharmacol Res; 2014 Dec; 90():1-17. PubMed ID: 25242635 [TBL] [Abstract][Full Text] [Related]
15. Genistein Suppresses Growth of Human Uterine Sarcoma Cell Lines via Multiple Mechanisms. Yeh CC; Fan Y; Jiang L; Yang YL; He B; You L; Mann M Anticancer Res; 2015 Jun; 35(6):3167-73. PubMed ID: 26026076 [TBL] [Abstract][Full Text] [Related]
16. Different effects of magnetic field on drug activity in human uterine sarcoma cell lines MES-SA and MES-SA/Dx5. Shibaki R; Kakikawa M Electromagn Biol Med; 2022 Jul; 41(3):343-351. PubMed ID: 35793396 [TBL] [Abstract][Full Text] [Related]
17. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY. Angelini A; Ciofani G; Conti P J Biol Regul Homeost Agents; 2015; 29(2):357-65. PubMed ID: 26122223 [TBL] [Abstract][Full Text] [Related]
18. PGRMC1-dependent autophagy by hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment. Zhu X; Ji M; Han Y; Guo Y; Zhu W; Gao F; Yang X; Zhang C Int J Oncol; 2017 Mar; 50(3):835-846. PubMed ID: 28197632 [TBL] [Abstract][Full Text] [Related]
19. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. Angelini A; Di Ilio C; Castellani ML; Conti P; Cuccurullo F J Biol Regul Homeost Agents; 2010; 24(2):197-205. PubMed ID: 20487633 [TBL] [Abstract][Full Text] [Related]
20. The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines. Angelini A; Centurione L; Sancilio S; Castellani ML; Conti P; Di Ilio C; Porreca E; Cuccurullo F; Di Pietro R J Biol Regul Homeost Agents; 2011; 25(2):203-11. PubMed ID: 21880209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]